A Study to Evaluate the Efficacy, Safety, & Tolerability of MYK-224 in

See also
Status	Clinical Trial	Phase
Completed	`NCT00253682` - Effects of Highly Active Anti-Retroviral Therapy on Cardiovascular Health in Infants of HIV-Infected Mothers	N/A
Recruiting	`NCT06034405` - Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
Terminated	`NCT04222101` - Association of Insulin Resistance and FGF21 on Cardiac Function in Pediatric Dilated Cardiomyopathy	N/A
Recruiting	`NCT05646056` - A Noninterventional, Single-Center Feasibility Study to Evaluate Measures of Heart Failure Risk
Completed	`NCT00692991` - Using Magnetic Resonance Imaging to Evaluate Heart Vessel Function After Angioplasty or Stent Placement Procedures	N/A
Withdrawn	`NCT04905173` - Comparison of Squat-to-Stand Maneuver With Amyl Nitrite, Valsalva, and Exercise Stress Echocardiography in Inducing Latent Left Ventricular Outflow Obstruction in Hypertrophic Cardiomyopathy	N/A
Recruiting	`NCT03251287` - Nitrite in Hypertrophic Cardiomyopathy (HCM) Study	Phase 1
Recruiting	`NCT01165749` - Exercise Study Including Patients With Hypertrophic Cardiomyopathy	N/A
Recruiting	`NCT03057002` - UTSW HP [13-C] Pyruvate Injection in HCM
Recruiting	`NCT02696135` - The Chinese Hypertrophic Cardiomyopathy Study(CHCS)
Recruiting	`NCT03040947` - MRI Sequence and Imaging Protocol Development
Active, not recruiting	`NCT02417311` - Individualized Early Risk Assessment for Heart Diseases
Completed	`NCT03225001` - PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - Nested Registry 3/Valve-in-Valve	N/A
Recruiting	`NCT05524077` - Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia	N/A
Completed	`NCT04164732` - Study of Efficacy of Oral Sacubitril/Valsartan in Adult Patients With Non-obstructive Hypertrophic Cardiomyopathy	Phase 2
Recruiting	`NCT06112743` - A Study to Evaluate Mavacamten Impact on Myocardial Structure in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy	Phase 4
Completed	`NCT00001871` - Study of Muscle Abnormalities in Patients With Specific Genetic Mutations	N/A
Completed	`NCT00001459` - Analysis of Heart Muscle Function in Patients With Heart Disease and Normal Volunteers	N/A
Completed	`NCT00005251` - Genetic Analysis of Familial Hypertrophic Cardiomyopathy	N/A
Completed	`NCT03450252` - Pacemaker Therapy for Drug-refractory Symptoms in Mid-cavity Hypertrophic Cardiomyopathy	N/A

NCT number	NCT05556343
Study type	Interventional
Source	Bristol-Myers Squibb
Contact	BMS Study Connect Contact Center www.BMSStudyConnect.com
Phone	855-907-3286
Email	Clinical.Trials@bms.com
Status	Recruiting
Phase	Phase 2
Start date	January 18, 2023
Completion date	August 20, 2026

A Study to Evaluate the Efficacy, Safety, and Tolerability of MYK-224 in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy — MERCUTIO

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms